SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMPO, Gianluca Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.643
AS - Asia 21.322
EU - Europa 14.858
SA - Sud America 3.614
AF - Africa 500
OC - Oceania 74
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 74.027
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.577
SG - Singapore 8.153
FI - Finlandia 4.768
CN - Cina 4.472
IT - Italia 3.077
BR - Brasile 2.805
VN - Vietnam 2.322
DE - Germania 1.983
HK - Hong Kong 1.703
BD - Bangladesh 1.339
GB - Regno Unito 969
FR - Francia 772
UA - Ucraina 733
TR - Turchia 645
JP - Giappone 627
CA - Canada 534
IN - India 531
PL - Polonia 499
RU - Federazione Russa 452
ID - Indonesia 408
SE - Svezia 379
MX - Messico 365
NL - Olanda 300
AR - Argentina 272
ZA - Sudafrica 188
ES - Italia 183
IQ - Iraq 182
CO - Colombia 138
PK - Pakistan 132
EC - Ecuador 131
AT - Austria 130
BE - Belgio 99
LT - Lituania 79
UZ - Uzbekistan 78
VE - Venezuela 77
PH - Filippine 76
SA - Arabia Saudita 76
MY - Malesia 71
AU - Australia 67
KR - Corea 67
IE - Irlanda 63
CH - Svizzera 58
MA - Marocco 58
CZ - Repubblica Ceca 54
CL - Cile 53
AE - Emirati Arabi Uniti 49
EG - Egitto 48
PY - Paraguay 44
TN - Tunisia 43
JO - Giordania 41
KE - Kenya 40
PE - Perù 38
JM - Giamaica 37
NP - Nepal 37
IR - Iran 33
UY - Uruguay 33
AL - Albania 32
TH - Thailandia 30
DZ - Algeria 26
LB - Libano 24
KZ - Kazakistan 23
PT - Portogallo 23
DO - Repubblica Dominicana 21
IL - Israele 21
TW - Taiwan 21
AZ - Azerbaigian 20
DK - Danimarca 20
KG - Kirghizistan 20
OM - Oman 19
RO - Romania 19
SN - Senegal 19
ET - Etiopia 18
HR - Croazia 18
CR - Costa Rica 16
PS - Palestinian Territory 16
NI - Nicaragua 15
RS - Serbia 15
BG - Bulgaria 14
MD - Moldavia 14
PA - Panama 14
CY - Cipro 13
HN - Honduras 13
HU - Ungheria 13
SI - Slovenia 13
SV - El Salvador 12
TT - Trinidad e Tobago 12
BO - Bolivia 11
GE - Georgia 11
GT - Guatemala 10
BH - Bahrain 9
GR - Grecia 9
LV - Lettonia 9
SK - Slovacchia (Repubblica Slovacca) 9
SY - Repubblica araba siriana 9
CI - Costa d'Avorio 8
NO - Norvegia 8
XK - ???statistics.table.value.countryCode.XK??? 8
BY - Bielorussia 7
GY - Guiana 7
KW - Kuwait 7
Totale 73.864
Salva come PNG Salva come JPEG
Città #
Singapore 4.931
Ashburn 4.716
Helsinki 4.367
San Jose 2.754
Fairfield 2.306
Woodbridge 1.819
Hong Kong 1.660
Santa Clara 1.528
Beijing 1.385
Dallas 1.383
Houston 1.253
Chandler 1.035
Munich 1.029
Seattle 988
New York 916
Wilmington 854
Ann Arbor 810
Los Angeles 775
Jacksonville 771
Cambridge 767
Ho Chi Minh City 764
Council Bluffs 684
Tokyo 592
Hanoi 519
Warsaw 469
Lauterbourg 413
Ferrara 386
Milan 348
Izmir 344
Princeton 326
São Paulo 311
Jakarta 296
Shanghai 287
Nanjing 272
Chicago 220
San Diego 216
Orem 213
London 212
Buffalo 211
Mexico City 211
Turku 187
Rome 182
Bologna 178
Toronto 176
Frankfurt am Main 159
Montreal 152
Boardman 146
Brooklyn 136
Atlanta 134
Chennai 131
Denver 126
Hefei 121
Phoenix 121
Nuremberg 115
Rio de Janeiro 110
The Dalles 107
Da Nang 104
Amsterdam 102
Haiphong 102
Boston 98
San Francisco 98
Stockholm 97
Brussels 96
Johannesburg 94
Moscow 94
Tianjin 89
Manchester 84
Poplar 81
Bremen 80
Washington 79
Shenyang 78
Mumbai 74
Falkenstein 73
Nanchang 72
Tashkent 69
Baghdad 64
Lappeenranta 64
Redwood City 64
Falls Church 63
Columbus 61
Ankara 58
Naples 56
Paris 56
Guangzhou 55
Jiaxing 55
Salt Lake City 55
Belo Horizonte 54
Dhaka 52
Dublin 52
Quito 51
Biên Hòa 48
Changsha 48
Charlotte 48
Medellín 48
Mountain View 44
Shenzhen 44
Brasília 43
New Delhi 43
Turin 43
Vienna 42
Totale 48.597
Salva come PNG Salva come JPEG
Nome #
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 2.866
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 2.057
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 436
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 424
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 415
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 375
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 374
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 360
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 346
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury 343
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 326
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 313
Atrial Longitudinal Strain Predicts New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis 304
Poor response to clopidogrel: current and future options for its management 299
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 298
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 293
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 285
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 283
How the functional assessment of culprit and non-culprit lesions may improve stratification and treatment of STEMI patients 275
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 270
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 263
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 261
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 260
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 258
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 257
The use of nutraceuticals to counteract atherosclerosis: The role of the Notch pathway 255
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 252
Characterization of Dermal Stem Cells of Diabetic Patients 252
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI 250
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review 250
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 249
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 248
Reperfusion Damage - A Story of Success, Failure, and Hope 246
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 246
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 244
The Mitochondrial Permeability Transition Pore 242
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 241
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 241
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 239
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 238
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 237
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 237
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 235
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 231
Mechanistic role of mPTP in ischemia-reperfusion injury 230
Transcatheter aortic-valve implantation with or without on-site cardiac surgery: The TRACS trial 229
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 229
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 228
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 227
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 224
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 223
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 221
Context-dependent function of ROS in the vascular endothelium: The role of the Notch pathway and shear stress 220
A serum proteome signature to predict mortality in severe COVID-19 patients 220
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 219
Can we improve myocardial protection during ischaemic injury? 219
Direct oral anticoagulants for the treatment of left ventricular thrombosis: an updated systematic review and meta-analysis 217
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 217
Effectiveness of a novel nutraceutical compound containing red yeast rice, polymethoxyflavones and antioxidants in the modulation of cholesterol levels in subjects with hypercholesterolemia and low-moderate cardiovascular risk: The NIRVANA study 217
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 215
BRS implantation in long lesions requiring device overlapping: Myth or reality? 215
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 215
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 215
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 212
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 208
Predicting return to work after acute myocardial infarction: Socio-occupational factors overcome clinical conditions 208
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 207
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 206
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 205
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 204
The Use of Multimodality Imaging for the Diagnosis of Myocardial Outpouchings and Invaginations: A Systematic Review 202
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 202
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents 202
Impact of COPD on Long-term Outcome After ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention 202
Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease 202
Notch Signaling Regulates Immune Responses in Atherosclerosis 201
Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease 201
Fractional flow reserve: Current applications and overview of the available data 200
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 200
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 200
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 200
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 199
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 199
Structural Abnormalities in Brugada Syndrome and Non-Invasive Cardiac Imaging: A Systematic Review 198
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 198
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 198
Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy 198
A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials 197
Drug-based cardiovascular prevention in patients with Marfan Syndrome: a systematic review 196
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study 195
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 194
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 194
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 194
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 193
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 193
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial 192
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 192
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 191
The in vitro effects of verbascoside on human platelet aggregation 190
Coronary Microvascular Dysfunction: PET, CMR and CT Assessment 190
Totale 28.437
Salva come PNG Salva come JPEG
Categoria #
all - tutte 343.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.176
Totale 345.673
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.161 274 287 207 148 146 163 193 195 142 239 337 830
2022/20232.784 340 126 141 235 406 396 177 251 360 71 191 90
2023/20242.794 169 292 130 91 214 490 132 281 68 128 142 657
2024/202512.666 313 330 920 586 1.425 1.211 806 708 2.320 1.302 1.514 1.231
2025/202639.345 2.969 1.574 3.299 3.858 4.751 2.088 3.630 1.945 7.207 3.898 2.448 1.678
2026/20271.224 1.224 0 0 0 0 0 0 0 0 0 0 0
Totale 75.311